Author:
Hong Ruey-Long,Tseng Yun-Long
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference29 articles.
1. Albalak A, Zeidel ML, Zucker SD, Jackson AA, Donovan JM (1996) Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes. Biochemistry 35:7936–7945
2. Alberts DS, Garcia DJ (1997) Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 54 [Suppl 4]:30–35
3. Bolognesi M, Merkel C, Bianco S, Angeli P, Sacerdoti D, Amodio P, Gatta A (1994) Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 19:628–634
4. Bukowski RM, Legha S, Saiki J, Eyre HJ, O'Bryan R (1982) Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study. Cancer Treat Rep 66:1651–1652
5. Chao Y, Chan WK, Birkhofer MJ, Hu OY, Wang SS, Huang YS, Liu M, Whang-Peng J, Chi KH, Lui WY, Lee SD (1998) Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer 78:34–39
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献